HRT Financial LP nets 743,791 WOK shares in Form 4

HRT Financial LP, a ten percent owner of WORK Medical Technology Group LTD, reported mixed trading in the company’s common stock.

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of WORK Medical Technology Group LTD, reported mixed trading in the company’s common stock. On June 17, 2026, it made an open-market purchase of 880,456 shares at $0.046 per share, bringing its holdings to 1,271,912 shares.

On June 18, 2026, HRT Financial LP executed an open-market sale of 136,665 shares at $3.87 per share, leaving it with 123,944 shares held directly. Overall, the filing shows a net increase of 743,791 shares in its position over these two days.

Insider Trade Summary

Net Buyer: 743,791 shares

Net Buy 2 txns

Insider HRT FINANCIAL LP

Role 10% Owner

Bought 880,456 shs ($41K)

Sold 136,665 shs ($529K)

Type	Security	Shares	Price	Value
Sale	Common Stock	136,665	$3.87	$529K
Purchase	Common Stock	880,456	$0.046	$41K

Holdings After Transaction: Common Stock — 123,944 shares (Direct)

Key Figures

Open-market purchase: 880,456 shares at $0.046/share Open-market sale: 136,665 shares at $3.87/share Holdings after purchase: 1,271,912 shares +3 more

6 metrics

Open-market purchase 880,456 shares at $0.046/share Common Stock bought on June 17, 2026

Open-market sale 136,665 shares at $3.87/share Common Stock sold on June 18, 2026

Holdings after purchase 1,271,912 shares Direct ownership after June 17, 2026 trade

Holdings after sale 123,944 shares Direct ownership after June 18, 2026 trade

Net shares bought 743,791 shares Net of reported buy and sell transactions

Insider status Ten percent owner HRT Financial LP role for WORK Medical Technology Group

Key Terms

open-market purchase, open-market sale, ten percent owner, non-derivative

4 terms

open-market purchase financial

"it made an open-market purchase of 880,456 shares at $0.046 per share"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

open-market sale financial

"executed an open-market sale of 136,665 shares at $3.87 per share"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner regulatory

"HRT Financial LP, a ten percent owner of WORK Medical Technology Group LTD"

non-derivative financial

"The Form 4 data for WORK Medical Technology Group shows only non-derivative common stock trades"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HRT Financial LP report for WOK?

HRT Financial LP reported one open-market purchase and one open-market sale of WORK Medical Technology Group common stock, resulting in a net increase of 743,791 shares in its position over June 17–18, 2026, according to the Form 4 data.

How many WORK Medical Technology Group (WOK) shares did HRT Financial LP buy and at what price?

HRT Financial LP bought 880,456 shares of WORK Medical Technology Group common stock at $0.046 per share on June 17, 2026. This open-market purchase increased its direct holdings to 1,271,912 shares immediately after that transaction, based on the Form 4 disclosure.

How many WOK shares did HRT Financial LP sell and at what price?

HRT Financial LP sold 136,665 shares of WORK Medical Technology Group common stock at $3.87 per share on June 18, 2026. This open-market sale reduced its direct holdings to 123,944 shares following the transaction, as reported in the Form 4 filing data.

What is HRT Financial LP’s remaining WOK stake after these transactions?

After completing the June 18, 2026 sale, HRT Financial LP directly holds 123,944 shares of WORK Medical Technology Group common stock. The Form 4 identifies HRT Financial LP as a ten percent owner, reflecting a significant shareholder position in the company’s equity.

Was HRT Financial LP a net buyer or net seller of WOK shares in this Form 4?

HRT Financial LP was a net buyer of WORK Medical Technology Group shares over the reported period. It purchased 880,456 shares and sold 136,665 shares, for a net increase of 743,791 shares in its common stock holdings, according to the transaction summary.

Did the WOK Form 4 show any derivative or option transactions for HRT Financial LP?

The Form 4 data for WORK Medical Technology Group shows only non-derivative common stock trades by HRT Financial LP. The derivative summary is empty, indicating no reported option, warrant, or other derivative exercises or conversions in this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 06:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		P		880,456	A	$0.046	1,271,912	D
Common Stock	06/18/2026		S		136,665	D	$3.87	123,944	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)